Matthew Plunkett
2013 - CTI BioPharma
In 2013, Matthew Plunkett earned a total compensation of $1.5M as Executive Vice President, Chief Business Officer at CTI BioPharma, a 374% increase compared to previous year.
Compensation breakdown
| Bonus | $260,000 |
|---|---|
| Option Awards | $427,410 |
| Salary | $325,000 |
| Stock Awards | $501,854 |
| Other | $9,119 |
| Total | $1,523,383 |
Plunkett received $501.9K in stock awards, accounting for 33% of the total pay in 2013.
Plunkett also received $260K in bonus, $427.4K in option awards, $325K in salary and $9.1K in other compensation.
Rankings
In 2013, Matthew Plunkett's compensation ranked 4,870th out of 12,286 executives tracked by ExecPay. In other words, Plunkett earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,870 out of 12,286 | 60th |
Division Manufacturing | 1,681 out of 4,612 | 64th |
Major group Chemicals And Allied Products | 481 out of 1,466 | 67th |
Industry group Drugs | 339 out of 1,160 | 71st |
Industry Pharmaceutical Preparations | 270 out of 890 | 70th |
Source: SEC filing on March 17, 2016.
Plunkett's colleagues
We found four more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2013.